← Back to Search

Behavioral Intervention

Relapse Prevention for Alcoholism (ARCH-RPA Trial)

N/A
Recruiting
Led By Heidi Hutton, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Confirmed diagnosis of HIV
Aged 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights

ARCH-RPA Trial Summary

This trial is testing a new computerized intervention for people with alcohol use disorders. The intervention is designed to help prevent relapse.

Who is the study for?
This trial is for adults over 18 with HIV who are patients at Johns Hopkins HIV Clinic. They must have a history of alcohol use disorder, varying drinking patterns, and currently be abstinent or drinking minimally. Non-English speakers, those acutely suicidal or unable to consent are excluded.Check my eligibility
What is being tested?
The study tests an adapted relapse prevention intervention for alcohol use disorders in people with HIV. It's a pilot trial comparing three groups: one gets computerized sessions, another person-delivered sessions, and the third group might receive usual care.See study design
What are the potential side effects?
Since this is a behavioral intervention focusing on relapse prevention rather than medication, typical drug side effects aren't expected. However, participants may experience emotional discomfort discussing their alcohol use.

ARCH-RPA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with HIV.
Select...
I am 18 years old or older.

ARCH-RPA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in time to relapse
Secondary outcome measures
Alcohol use pattern as assessed by change in number of days abstinent
Alcohol use pattern as assessed by change in number of drinking days
Alcohol use pattern as assessed by change in number of drinks per drinking day
+1 more

ARCH-RPA Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Person delivered RPIExperimental Treatment1 Intervention
2 session counselor delivered counseling to prevent relapse to hazardous drinking
Group II: Computer delivered RPIExperimental Treatment1 Intervention
2 session computer delivered counseling to prevent relapse to hazardous drinking
Group III: Treatment as UsualActive Control1 Intervention
Counseling for alcohol use available in clinic as treatment as usual

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
796 Previous Clinical Trials
1,361,273 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,245 Previous Clinical Trials
14,815,956 Total Patients Enrolled
Heidi Hutton, PhDPrincipal InvestigatorJohns Hopkins School of Medicine

Media Library

Relapse Prevention Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05163301 — N/A
HIV/AIDS Research Study Groups: Person delivered RPI, Treatment as Usual, Computer delivered RPI
Relapse Prevention Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05163301 — N/A
HIV/AIDS Clinical Trial 2023: Relapse Prevention Intervention Highlights & Side Effects. Trial Name: NCT05163301 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any openings for this clinical trial?

"As per clinicaltrials.gov, this medical trial is not actively accepting participant applications at the moment. Although it was first advertised on January 30th 2023 and last updated July 20th 2022, there are currently 504 other trials searching for volunteers."

Answered by AI
~97 spots leftby Feb 2026